ABVC BioPharma, Inc. Payments to Acquire Loans Receivable
ABVC BioPharma, Inc. (ABVC) reported Payments to Acquire Loans Receivable of $469.63 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLoansReceivable · last filed 2020-11-17
- ABVC BioPharma, Inc. payments to acquire loans receivable for the quarter ending 2019-12-31 was $108.00.
- ABVC BioPharma, Inc. payments to acquire loans receivable for the quarter ending 2019-09-30 was $14.16K.
- ABVC BioPharma, Inc. payments to acquire loans receivable for fiscal 2019 was $17.50K.
| Period end | Payments to Acquire Loans Receivable 3 month | Payments to Acquire Loans Receivable 6 month | Payments to Acquire Loans Receivable 9 month | Payments to Acquire Loans Receivable 12 month |
|---|---|---|---|---|
| 2020-09-30 | $469.63K 10-Q · filed 2020-11-17 | |||
| 2019-12-31 | $108.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | $14.27K derived: sum of 2 quarters · filed 2020-11-17 | $17.50K 10-K · filed 2020-05-15 | |
| 2019-09-30 | $14.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $17.39K 10-Q · filed 2020-11-17 | ||
| 2019-06-30 | $3.23K 10-Q · filed 2020-08-14 |